Searched for
GENERIC VERSIONS OF OZEMPIC
India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...09 Jun, 2026, 05.30 AM IST- Why are Indians suddenly buying more vitamins after starting Ozempic-like weight loss drugs?Demand for vitamin and nutritional supplements is surging in India. This trend follows the increased availability of semaglutide-based weig...22 May, 2026, 05.08 PM IST
- Emcure slashes prices of weight management drug Poviztra by up to 55%Emcure Pharmaceuticals is making its weight management drug Poviztra more accessible. The price of the semaglutide injection will be cut by...02 Apr, 2026, 07.39 PM IST
- GLP-1 impact: Jefferies sees these 3 stocks as winners in the race for Ozempic, Wegovy genericsIndian drug makers are launching affordable generic Semaglutide, the active ingredient in popular weight-loss drugs. Sun Pharma, Lupin, and...27 Mar, 2026, 02.22 PM IST
- Weight is over! Pharma stocks jump up to 4% as patent for Ozempic's key ingredient expires; what lies ahead?Pharma stocks rose up to 4% as Novo Nordisk’s semaglutide patent nears expiry, raising expectations of cheaper generics in India. Strong gr...20 Mar, 2026, 12.40 PM IST
- The weight is over. This injectable fits the billIndia's diabetes and weight-loss drug market is set for a major shift. Novo Nordisk's popular drug semaglutide is now off patent. Over 40 c...20 Mar, 2026, 08.09 AM IST
- Zydus partners with Lupin to co-market generic semaglutide in IndiaZydus Lifesciences and Lupin are joining forces. They will make a generic version of the popular weight-loss and diabetes drug semaglutide ...17 Mar, 2026, 02.23 PM IST
- Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources sayDr Reddy's Laboratories is poised to launch its generic semaglutide injection, potentially named Obeda, in India by March. This move antici...25 Feb, 2026, 01.32 PM IST
- Dr Reddy's says Wegovy copycat to be priced competitively, with 50-60% discounts feasibleIndian drugmaker Dr Reddy's Laboratories is set to launch a generic version of the popular weight-loss drug Wegovy. The company aims to off...17 Feb, 2026, 10.36 PM IST
- Delhi HC allows Sun Pharma to manufacture, export its own weight loss drugThe Delhi High Court has allowed Sun Pharma to manufacture and export its version of semaglutide, the diabetes and anti-obesity drug made b...10 Dec, 2025, 11.56 AM IST
- Novo Nordisk gears up for December Ozempic launch in India, sources sayDanish drugmaker Novo Nordisk is set to launch its popular diabetes drug Ozempic in India this month. This move aims to capture a significa...04 Dec, 2025, 10.21 AM IST
- Weight-loss drug Ozempic to debut in India soonNovo Nordisk will launch Ozempic in India. This injectable drug manages type 2 diabetes and aids weight loss. It enters a competitive marke...26 Sep, 2025, 11.36 PM IST
- Biocon plans to launch generic Wegovy obesity drug in India by 2027, CEO saysBiocon is set to launch generic versions of Wegovy in India and Canada, aiming for market entry by late 2026 or early 2027. This strategic ...16 Jul, 2025, 06.39 PM IST
- Biocon eyes Canadian bonanza from generics of weight-loss 'super-drugs' Ozempic and WegovyBiocon Ltd. is set to seek regulatory approvals for generic versions of Novo Nordisk's Ozempic and Wegovy, targeting key markets like Canad...02 Jul, 2025, 08.15 AM IST
- Biocon drops plan to launch weight-loss drugs in China, executive saysBiocon has scrapped its plans to introduce generic versions of Novo Nordisk's Ozempic and Wegovy in China, citing intense local competition...27 Jun, 2025, 10.36 AM IST
- Biocon seeks partner to test generic Wegovy, Ozempic in ChinaIndia's Biocon is seeking a Chinese partner to conduct clinical trials on generic versions of Novo Nordisk's popular diabetes drug Ozempic ...20 Jun, 2024, 04.01 PM IST
- Weight-loss medicines: Biocon eyes a $100 billion jackpot with weighty pivotWeight-loss drugs: Biocon Ltd. is shifting focus to anti-obesity therapies as patents for key medications expire, leading to a surge in gen...08 Apr, 2024, 09.25 AM IST
Load More
